[go: up one dir, main page]

WO2006106994A8 - Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. - Google Patents

Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. Download PDF

Info

Publication number
WO2006106994A8
WO2006106994A8 PCT/JP2006/306978 JP2006306978W WO2006106994A8 WO 2006106994 A8 WO2006106994 A8 WO 2006106994A8 JP 2006306978 W JP2006306978 W JP 2006306978W WO 2006106994 A8 WO2006106994 A8 WO 2006106994A8
Authority
WO
WIPO (PCT)
Prior art keywords
drug
periodontal disease
aesculus hippocastanum
component extracted
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2006/306978
Other languages
French (fr)
Japanese (ja)
Other versions
WO2006106994A1 (en
Inventor
恵介 梶田
英寿 金
秀晃 北郡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of WO2006106994A1 publication Critical patent/WO2006106994A1/en
Anticipated expiration legal-status Critical
Publication of WO2006106994A8 publication Critical patent/WO2006106994A8/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

[PROBLEMS] To provide a novel drug for periodontal disease which has an excellent effect of inhibiting abnormal extension of a gingival epithelial tissue. [MEANS FOR SOLVING PROBLEMS] A drug for periodontal disease containing a component which is obtained by extracting Aesculus hippocastanum L. with a solvent and isolating; and a composition to be used in the oral cavity for treating oral diseases such as gingivitis and periodontitis which contains the above drug.
PCT/JP2006/306978 2005-03-31 2006-03-31 Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. Ceased WO2006106994A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005-103745 2005-03-31
JP2005103745A JP2006282562A (en) 2005-03-31 2005-03-31 Agent for periodontosis compounded with aesculus hippocastanum l. extract component

Publications (2)

Publication Number Publication Date
WO2006106994A1 WO2006106994A1 (en) 2006-10-12
WO2006106994A8 true WO2006106994A8 (en) 2009-08-27

Family

ID=37073544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/306978 Ceased WO2006106994A1 (en) 2005-03-31 2006-03-31 Drug for periodontal disease comprising component extracted from aesculus hippocastanum l.

Country Status (2)

Country Link
JP (1) JP2006282562A (en)
WO (1) WO2006106994A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5710111B2 (en) * 2009-07-14 2015-04-30 株式会社ロッテ Antibacterial agent consisting of lactitol and maltitol
KR20230033488A (en) * 2021-09-01 2023-03-08 주식회사 안지오랩 Composition comprising the the horse chestnut extracts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5758613A (en) * 1980-09-26 1982-04-08 Lion Corp Composition for oral cavity application
JPS5782307A (en) * 1980-11-12 1982-05-22 Lion Corp Composition for oral purpose
DE3241017C1 (en) * 1982-11-06 1983-12-15 Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz Dental and oral care products
KR0138248B1 (en) * 1992-10-07 1998-05-15 최근선 Oral Hygiene Composition Containing Plant Extracts
JP3570482B2 (en) * 1997-12-02 2004-09-29 ライオン株式会社 Dentifrice composition and method for suppressing bitterness
FR2799369B1 (en) * 1999-10-08 2001-12-21 Oreal COMBINATION OF ESCINE AND DEXTRAN SULFATE AND THE USE THEREOF
WO2002047701A1 (en) * 2000-12-12 2002-06-20 Angiolab, Inc. Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
WO2003035092A1 (en) * 2001-10-26 2003-05-01 Angiolab Inc. Composition containing horse chestnut extract for anti-angiogenic and matrix metalloproteinase inhibitory activity

Also Published As

Publication number Publication date
JP2006282562A (en) 2006-10-19
WO2006106994A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
WO2008070368A3 (en) Methods and compositions for skin care
WO2006110406A3 (en) Compositions comprising probiotic and sweetener components
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
WO2007087461A3 (en) Use of gallium to treat biofilm-associated infectons
WO2011019468A3 (en) Topical composition with skin lightening effect
WO2007077259A8 (en) Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds
SI1819227T1 (en) Pharmaceutical formulation of decitabine
MX2009006695A (en) N-substituted-p-menthane-3-carboxamide and uses thereof.
MY149181A (en) Isoxazoline derivative and preparation process thereof
EA201200892A1 (en) COMPOSITION FOR ORAL HYGIENE
WO2007130821A3 (en) Mglur5 modulators ii
WO2010121213A3 (en) Antibacterial compositions
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
MX341211B (en) Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions.
DE502005010342D1 (en) Substituierte cyclohexylessigsäure-derivate
WO2005055943A3 (en) Vinorelbine derivatives
BRPI0411087A (en) improvements in or related to organic compounds
DE602004019528D1 (en) COMPOSITIONS FOR TREATING RECURRENT APHTHS IN THE MOUTH VALVE
WO2008033935A3 (en) Vinorelbine derivatives
WO2006106994A8 (en) Drug for periodontal disease comprising component extracted from aesculus hippocastanum l.
WO2008023003A8 (en) Drug combinations for treating airway diseases
ATE433450T1 (en) SUBSTITUTED 1,4,8-TRIAZASPIRO 4.5 DECAN-2-ON COMPOUNDS
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
GEP20125563B (en) 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same
MY150686A (en) Oral composition containing morin

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06730926

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP